CAMPATH-1H monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's lymphomas: a phase II multicenter study. European Study Group of CAMPATH-1H Treatment in Low-Grade Non-Hodgkin's Lymphoma.
Jeanette Lundin(Karolinska University Hospital), Håkan Mellstedt(Karolinska University Hospital), Roel Willemze(Leiden University Medical Center), Andreas Engert(University of Cologne), Anders Österborg(Karolinska University Hospital), Christian Gisselbrecht(Institut Universitaire de France), Jacob G. Thomas, D. Huhn(Universität Innsbruck), M. Uppenkamp, A. A. Epenetos, Robert Marcus(King's College Hospital), Elaine M. Rankin(The Netherlands Cancer Institute), R. Stahel, C Poynton, D. Crowther(Radboud University Nijmegen), G. Brittinger, Hervé Dombret(University of London Institute in Paris), Ulrich Jaeger(Medical University of Vienna), Nicholas Nissen(University of California, Los Angeles)
Cited by 258
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k